Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

Leukemia. 2020 Jul;34(7):1972. doi: 10.1038/s41375-020-0706-3.

Melanie Kahl^{1

2}, Annamaria Brioli^{1

3}, Martin Bens⁴, Florian Perner^{1

4

5}, Anne Kresinsky⁴, Ulf Schnetzke¹, Anna Hinze¹, Yordan Sbirkov⁶, Sven Stengel⁷, Giorgia Simonetti⁸, Giovanni Martinelli^{8

9}, Kevin Petrie¹⁰, Arthur Zelent¹¹, Frank-Dietmar Böhmer², Marco Groth⁴, Thomas Ernst¹, Florian H Heidel^{1

4}, Sebastian Scholl¹, Andreas Hochhaus¹, Tino Schenk^{12

13}

¹ Department of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany.
² Institute of Molecular Cell Biology, Center for Molecular Biomedicine Jena (CMB), Jena University Hospital, Jena, Germany.
³ Else-Kröner-Forschungskolleg, Jena, Germany.
⁴ Leibniz-Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.
⁵ Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
⁶ Department of Medical Biology, Medical University-Plovdiv, Plovdiv, Bulgaria.
⁷ Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.
⁸ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
⁹ Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
¹⁰ School of Natural Sciences, University of Stirling, Stirling, UK.
¹¹ Millitary Institute of Hygiene and Epidemiology, Warsaw, Poland.
¹² Department of Hematology/Oncology, Clinic of Internal Medicine II, Jena University Hospital, Jena, Germany. tino.schenk@med.uni-jena.de.
¹³ Institute of Molecular Cell Biology, Center for Molecular Biomedicine Jena (CMB), Jena University Hospital, Jena, Germany. tino.schenk@med.uni-jena.de.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.